Domestic deals of venture capital investment in Chinese life science 2018, by company
In 2018, the Chinese drug firm Moderna Therapeutics raised about 500 million U.S. dollars of domestic venture capital (VC) investment. The investors included Abu Dhabi Investment Bureau,Sequoia, BB Biotech AG, and Arrowmark Partners. China Diagnostic Medical received the second highest domestic investment of 292 million U.S. dollars.